Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DE vs GSK✓SelectedUSD · GSKDE vs GSK performance historyLatest closeAs of-2.50%11/20
Stock and ETF performance explorer

DE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+668.5%
GSK return
+97.4%
Excess return
+571.1%
Maximum drawdown
-37.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.5%-0.1%-2.4%-2.5%
7D-9.5%-5.3%-4.2%-7.9%
30D-4.3%-3.7%-0.6%-3.2%
3M-1.6%-7.3%+5.6%+0.6%
6M+9.2%-4.2%+13.5%+10.1%
YTD+31.9%+0.9%+31.0%+30.4%
1Y+29.4%+7.3%+22.1%+25.3%
3Y+66.7%+52.7%+14.0%+38.2%
5Y+87.9%+40.1%+47.7%+57.4%
All+668.5%+97.4%+571.1%+455.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling